Molecular interaction of neurocalcin alpha with alsin (ALS2).

Neurosci Lett

Division of Biology, Graduate School of Science, Kobe-University, Rokkodaicho 1-1, Nada-ku, Kobe 657-8501, Japan.

Published: June 2008

Membrane microdomains (MDs), or lipid rafts, are recently identified dynamic membrane domains on which various signal-transductions are performed. Intracellular Ca(2+)-binding proteins participate in the Ca(2+) signaling through interaction with various proteins. Neurocalcin alpha (NCalpha) is a member of neuronal calcium sensor (NCS) protein family and shows Ca(2+)-dependent binding to the cell membrane through N-terminal myristoyl moiety. Since NCalpha was identified as a Ca(2+)-dependent binding protein to neuronal MDs, its binding proteins may participate in the signal-transduction on the MDs. In an immunoprecipitate using anti-NCalpha antibody, alsin (ALS2), a protein product of one of the responsive genes for amyotrophic lateral sclerosis, was detected through LC-MS/MS. Specific antibody to alsin was produced and immunoprecipitation using this antibody showed co-sedimentation of NCalpha. Some part of alsin bound to brain-derived MD fraction in the presence of Ca(2+) ions and eluted out by the chelation of Ca(2+) ions, as in the case of NCalpha. Immunostaining of cultured neurons showed broad distribution of alsin and NCalpha, and membrane association of these proteins were increased through Ca(2+) loading by maitotoxin. These results suggest that alsin binds cell membrane in a Ca(2+)-dependent manner through NCalpha and regulates membrane dynamics.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2008.04.066DOI Listing

Publication Analysis

Top Keywords

neurocalcin alpha
8
alsin als2
8
proteins participate
8
ca2+-dependent binding
8
cell membrane
8
antibody alsin
8
ca2+ ions
8
alsin
6
membrane
6
ncalpha
6

Similar Publications

Article Synopsis
  • A study was conducted to examine the expression of calsyntenin-1 (Clstn1) in the brains of rats using lithium-pilocarpine to induce seizures.
  • Rats that had spontaneous seizures were divided into the epilepsy group and a control group, and Clstn1 expression was evaluated using various scientific techniques.
  • Additional groups of rats underwent status epilepticus treatment, with some receiving a lentivirus targeting Clstn1 to investigate its potential role in seizure frequency and latency over 8 weeks.
View Article and Find Full Text PDF

Aim: To observe changes in the serum levels of visinin-like protein-1 (VILIP-1), caveolin-1 (Cav-1) and neuron-specific enolase (NSE) after glioma resection.

Material And Methods: Consecutive 14 glioma patients with different histologic grade and 14 age and gender-matched healthy subjects were included in this pilot study. From the patients serum samples were taken in preoperative and on day 2 and 10 of postoperative periods.

View Article and Find Full Text PDF

Objective: This study aimed to compare serum levels of CD163, YKL-40, and VILIP-1 between children with autism spectrum disorder (ASD) and healthy controls, while also investigating their association with the severity of ASD and language development.

Methods: The study included 40 ASD-diagnosed patients (aged 18-72 months) and 40 age-matched healthy controls. Childhood Autism Rating Scale, Preschool Language Scale-4, and Ankara Development Screening Inventory were administered to children in the ASD group.

View Article and Find Full Text PDF
Article Synopsis
  • Biomarkers of synaptic damage, specifically SNAP-25 and VILIP-1, were analyzed in patients with severe traumatic brain injury (TBI) to assess their relationship with injury severity and outcomes.* ! -
  • Elevated levels of SNAP-25 and VILIP-1 in cerebrospinal fluid (CSF) shortly after TBI are linked to poorer long-term outcomes, indicating their potential as reliable indicators of synaptic damage.* ! -
  • The study suggests that these synaptic damage markers are more indicative of unfavorable outcomes compared to other traditional neuroaxonal injury markers and correlate with inflammation following TBI.* !
View Article and Find Full Text PDF

Alzheimer's disease (AD) is currently constrained by limited clinical treatment options. The initial pathophysiological event, which can be traced back to decades before the clinical symptoms become apparent, involves the excessive accumulation of amyloid-beta (Aβ), a peptide comprised of 40-42 amino acids, in extraneuronal plaques within the brain. Biochemical and histological studies have shown that overaccumulation of Aβ instigates an aberrant escalation in the phosphorylation and secretion of tau, a microtubule-binding axonal protein.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!